Jane Street
ASND icon

Jane Street’s Ascendis Pharma A/S ASND Stock Holding History

Jane Street’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.29M Buy
10,000
+800
+9% +$179K ﹤0.01% 4824
2025
Q4 		$1.96M Sell
9,200
-4,700
-34% -$971K ﹤0.01% 4849
2025
Q3 		$2.76M Buy
13,900
+10,100
+266% +$1.88M ﹤0.01% 4366
2025
Q2 		$656K Sell
3,800
-70,000
-95% -$11.4M ﹤0.01% 6435
2025
Q1 		$11.5M Sell
73,800
-37,600
-34% -$5.37M ﹤0.01% 1823
2024
Q4 		$15.3M Buy
111,400
+33,700
+43% +$4.43M ﹤0.01% 1486
2024
Q3 		$11.6M Buy
77,700
+37,600
+94% +$5.08M ﹤0.01% 1767
2024
Q2 		$5.47M Buy
40,100
+1,200
+3% +$163K ﹤0.01% 2839
2024
Q1 		$5.88M Sell
38,900
-9,200
-19% -$1.31M ﹤0.01% 2403
2023
Q4 		$6.06M Sell
48,100
-19,200
-29% -$1.91M ﹤0.01% 2587
2023
Q3 		$6.3M Buy
67,300
+14,600
+28% +$1.37M ﹤0.01% 2310
2023
Q2 		$4.7M Buy
52,700
+12,000
+29% +$1.04M ﹤0.01% 2829
2023
Q1 		$4.36M Buy
40,700
+10,100
+33% +$1.16M ﹤0.01% 2640
2022
Q4 		$3.74M Buy
30,600
+13,300
+77% +$1.54M ﹤0.01% 2894
2022
Q3 		$1.79M Sell
17,300
-19,500
-53% -$1.85M ﹤0.01% 4381
2022
Q2 		$3.42M Sell
36,800
-4,500
-11% -$424K ﹤0.01% 3233
2022
Q1 		$4.85M Buy
41,300
+24,500
+146% +$2.84M ﹤0.01% 3079
2021
Q4 		$2.26M Sell
16,800
-14,300
-46% -$2.13M ﹤0.01% 4232
2021
Q3 		$4.96M Buy
31,100
+25,000
+410% +$3.42M ﹤0.01% 2745
2021
Q2 		$802K Buy
6,100
+3,900
+177% +$520K ﹤0.01% 6311
2021
Q1 		$284K Sell
2,200
-18,900
-90% -$2.87M ﹤0.01% 7774
2020
Q4 		$3.52M Buy
+21,100
New +$3.49M ﹤0.01% 2588

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jane Street's ASND Position: Q1 2026 in Review

Jane Street sold out of Ascendis Pharma A/S (ASND) in Q1 2026, closing a stake of 21,225 shares — an estimated $4.76M sold.

Jane Street first reported a position in ASND in Q3 2017 and held it in 23 quarters. The position peaked at $7.53M in Q1 2025. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Jane Street reported no remaining Ascendis Pharma A/S position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 21,225 Ascendis Pharma A/S shares in Q1 2026, an estimated $4.76M.
  • Jane Street first reported a position in Ascendis Pharma A/S in Q3 2017 and held it in 23 quarters.
  • Jane Street's Ascendis Pharma A/S position peaked at $7.53M in Q1 2025.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.